Managing Director of the Oceania region
Michala Fischer-Hansen is the Managing Director of the Oceania region (Australia & New Zealand), Novo Nordisk Pharmaceuticals Pty Ltd, a role she has held since April 2016.
Michala holds an extensive experience within the pharmaceutical industry, having worked in Novo Nordisk for 17 years. Michala has held positions in Novo Nordisk Headquarter in the area of global strategy and execution, specifically, within pricing, pharmacoeconomics, strategic marketing and management and communication. Michala has also worked for the Novo Nordisk US organisation, where she worked in the commercial part of the business within Marketing Effectiveness.
In 2014 Michala returned to Novo Nordisk Denmark as Senior Global Marketing Director and was in June 2015 promoted to Corporate Vice President in Global Marketing. In this role, Michala was responsible for the commercialisation, global rollout and life cycle management of a new line of diabetes products.
Michala holds a Masters degree in International Business from Copenhagen Business School and is a Danish citizen.
About Novo Nordisk
At Novo Nordisk,
we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries. Our Australian affiliate is located in Sydney employing more than 100 people across Australia and New Zealand.
Add a background on Novo Nordisk. You can get this from any company announcement or press release.